These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a novel sandwich immunoassay based on targeting recombinant Francisella outer membrane protein A for the diagnosis of tularemia. Jang J; Kwon DH; Jang JH; Lee DG; Chang SH; Jeon MY; Jeong YS; Song DH; Min JK; Park JG; Lee MS; Han BS; Yang W; Lee NK; Lee J Front Cell Infect Microbiol; 2024; 14():1455259. PubMed ID: 39228894 [TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia. Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754 [TBL] [Abstract][Full Text] [Related]
4. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Fulop M; Manchee R; Titball R Vaccine; 1995 Sep; 13(13):1220-5. PubMed ID: 8578807 [TBL] [Abstract][Full Text] [Related]
5. Analysis of a cloned Francisella tularensis outer membrane protein gene and expression in attenuated Salmonella typhimurium. Leslie DL; Cox J; Lee M; Titball RW FEMS Microbiol Lett; 1993 Aug; 111(2-3):331-5. PubMed ID: 8405941 [TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R; Harris G; Conlan JW; Chen W Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863 [TBL] [Abstract][Full Text] [Related]
7. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348 [TBL] [Abstract][Full Text] [Related]
9. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria. Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853 [TBL] [Abstract][Full Text] [Related]
10. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751 [TBL] [Abstract][Full Text] [Related]
11. Immunological markers that correlate with protection immunity against tularemia infection. Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607 [TBL] [Abstract][Full Text] [Related]
12. Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo. Straskova A; Spidlova P; Mou S; Worsham P; Putzova D; Pavkova I; Stulik J Pathog Dis; 2015 Nov; 73(8):ftv058. PubMed ID: 26253078 [TBL] [Abstract][Full Text] [Related]
13. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332 [TBL] [Abstract][Full Text] [Related]
15. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain. Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232 [TBL] [Abstract][Full Text] [Related]
16. Identification, cloning, expression, and purification of Francisella lpp3: an immunogenic lipoprotein. Parra MC; Shaffer SA; Hajjar AM; Gallis BM; Hager A; Goodlett DR; Guina T; Miller S; Collins CM Microbiol Res; 2010 Sep; 165(7):531-45. PubMed ID: 20006480 [TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
18. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Lavine CL; Clinton SR; Angelova-Fischer I; Marion TN; Bina XR; Bina JE; Whitt MA; Miller MA Eur J Immunol; 2007 Nov; 37(11):3007-20. PubMed ID: 17960662 [TBL] [Abstract][Full Text] [Related]
19. Virulence of representative Japanese Francisella tularensis and immunologic consequences of infection in mice. Hotta A; Fujita O; Uda A; Yamamoto Y; Sharma N; Tanabayashi K; Yamada A; Morikawa S Microbiol Immunol; 2016 Mar; 60(3):168-76. PubMed ID: 26853540 [TBL] [Abstract][Full Text] [Related]
20. [The effect of recombinant tumor necrosis factor on antibody formation in mice immunized with a preparation of the outer membranes from Francisella tularensis]. Iurov SV; Pchelintsev SIu; Denisov LA; Afanas'eva SS; Uraeva VI; Denisova NB; Cherenkova GV; Vorob'ev AA Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):64-7. PubMed ID: 7653140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]